These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1769554)

  • 41. Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.
    Gülke I; Pfeifer G; Liese J; Fritz M; Hofmann F; Aktories K; Barth H
    Infect Immun; 2001 Oct; 69(10):6004-11. PubMed ID: 11553537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lethal and dermonecrotic activities of Clostridium perfringens lota toxin: biological activities induced by cooperation of two nonlinked components.
    Sakurai J; Kobayashi K
    Microbiol Immunol; 1995; 39(4):249-53. PubMed ID: 7651239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A highly sensitive enzyme-linked immunosorbent assay for Clostridium perfringens enterotoxin.
    Uemura T; Yoshitake S; Hu D; Kajikawa T
    Lett Appl Microbiol; 1992 Jul; 15(1):23-5. PubMed ID: 1368348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Clostridium perfringens iota toxin in the small intestine of mice.
    Redondo LM; Redondo EA; Dailoff GC; Leiva CL; Díaz-Carrasco JM; Bruzzone OA; Cangelosi A; Geoghegan P; Fernandez-Miyakawa ME
    Anaerobe; 2017 Dec; 48():83-88. PubMed ID: 28764997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production and evaluation of a monoclonal antibody to Clostridium perfringens type D epsilon toxin.
    El-Enbaawy MI; Abdalla YA; Hussein AZ; Osman RM; Selim SA
    Egypt J Immunol; 2003; 10(1):77-81. PubMed ID: 15719625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A latex agglutination test for the qualitative detection of Clostridium perfringens epsilon toxin.
    Martin PK; Naylor RD
    Res Vet Sci; 1994 Mar; 56(2):259-61. PubMed ID: 8191019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.
    Ebert E; Oppling V; Werner E; Cussler K
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):299-311. PubMed ID: 10397315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two
    Diancourt L; Sautereau J; Criscuolo A; Popoff MR
    Toxins (Basel); 2019 Mar; 11(3):. PubMed ID: 30823654
    [No Abstract]   [Full Text] [Related]  

  • 49. Measurement of Clostridium perfringens beta-toxin production by surface plasmon resonance immunoassay.
    Hsieh HV; Stewart B; Hauer P; Haaland P; Campbell R
    Vaccine; 1998; 16(9-10):997-1003. PubMed ID: 9682350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detergent-resistant membrane microdomains facilitate Ib oligomer formation and biological activity of Clostridium perfringens iota-toxin.
    Hale ML; Marvaud JC; Popoff MR; Stiles BG
    Infect Immun; 2004 Apr; 72(4):2186-93. PubMed ID: 15039342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genotyping of Clostridium perfringens toxins using multiple oligonucleotide microarray hybridization.
    Al-Khaldi SF; Myers KM; Rasooly A; Chizhikov V
    Mol Cell Probes; 2004 Dec; 18(6):359-67. PubMed ID: 15488374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crystallization and preliminary X-ray studies of the Ia component of Clostridium perfringens iota toxin complexed with NADPH.
    Tsuge H; Nagahama M; Nishimura T; Sakaguchi Y; Katunuma N; Sakurai J
    J Struct Biol; 1999 Jun; 126(2):175-7. PubMed ID: 10388629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clostridium perfringens iota-toxin, ADP-ribosyltransferase: structure and mechanism of action.
    Sakurai J; Nagahama M; Hisatsune J; Katunuma N; Tsuge H
    Adv Enzyme Regul; 2003; 43():361-77. PubMed ID: 12791397
    [No Abstract]   [Full Text] [Related]  

  • 54. EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin.
    Schnell L; Mittler AK; Sadi M; Popoff MR; Schwan C; Aktories K; Mattarei A; Azarnia Tehran D; Montecucco C; Barth H
    Toxins (Basel); 2016 Apr; 8(4):101. PubMed ID: 27043629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cathepsin Release from Lysosomes Promotes Endocytosis of
    Nagahama M; Kobayashi K; Takehara M
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sandwich enzyme-linked immunosorbent assay by using monoclonal antibody for detection of Clostridium perfringens enterotoxin.
    Piyankarage RH; Tajima T; Sugii S; Uemura T
    J Vet Med Sci; 1999 Jan; 61(1):45-7. PubMed ID: 10027163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An alternative to the toxin neutralization assay in mice for the potency testing of the Clostridium tetani, Clostridium septicum, Clostridium novyi type B and Clostridium perfringens type D epsilon components of multivalent sheep vaccines.
    Wood KR
    Biologicals; 1991 Oct; 19(4):281-6. PubMed ID: 1797039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation of Clostridium perfringens binary iota-toxin pore complex for structural analysis using cryo-EM.
    Yamada T; Tsuge H
    Methods Enzymol; 2021; 649():125-148. PubMed ID: 33712185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ; Clough NE
    Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toxin genotyping of Clostridium perfringens strains using a polymerase chain reaction protocol.
    Badagliacca P; Di Provvido A; Scattolini S; Pompei G; Di Giannatale E
    Vet Ital; 2010; 46(1):113-8, 107-12. PubMed ID: 20391372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.